In 2018, a new class of medications was approved by the FDA for the prevention of migraine in adults. These drugs are referred to as calcitonin gene-related peptide (CGRP) inhibitors. There are currently multiple CGRP medications on the market. Dosing, frequency of use and method of action vary.
The financial assistance guide below is for anyone who has been prescribed Vyepti by their healthcare provider. Vyepti is one of multiple new CGRP inhibitors approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, review the details provided below to see if you qualify for the manufacturer’s financial assistance programs.
Most insurance companies have added at least one or two of these CGRP inhibitors to the list of medicines they cover; however, patients still struggle to receive insurance approval for the prescribed CGRP inhibitor. Each pharmaceutical company is offering financial assistance programs to help cover and/or to help cover the cost of high copays. Each program is different and various programs exist to support patients with private, government-funded insurance, as well as the uninsured.
To help patients understand each program, CHAMP created Financial Assistance Guides for the three CGRP inhibitors. These guides are not produced or approved by the medication manufacturers. CHAMP is not endorsing the use of any CGRP inhibitor over another, nor promoting the use of this new class of preventive medications for everyone with migraine disease. Every patient needs to consult their healthcare provider to determine if CGRP inhibitors are right for you.
I Have Been Prescribed Vyepti. What Financial Assistance Programs Exists To Help Me?
Find your insurance coverage and see what Financial Assistance Programs exist to help.
I Have a Private/Commercial Insurance Plan
This category includes insurance plans provided through an employer, purchased with subsidy support from the Affordable Care Act (Obamacare) or purchased privately.
Highlights of Vyepti Copay Assistance Program
There may be assistance to help you save on the cost of VYEPTI. If you have commercial insurance, you may be eligible to save on the cost of treatment through the VYEPTI CONNECT Copay Assistance Program. You may pay as little as $0 per infusion, every 3 months.* Offer includes up to $200 in administration fees per VYEPTI treatment. SEE FULL DETAILS AT THE VYEPTI SITE.
- VYEPTI CONNECT Copay Assistance Program will determine your eligibility, if you enroll
- When your enrollment is complete and approved, you and your healthcare provider will receive a confirmation letter that contains your copay program information
- You can save on copay if you meet all the VYEPTI CONNECT Copay Assistance Program Terms and Conditions
You could save on your copay if you
You may be eligible for direct reimbursement from the VYEPTI CONNECT Copay Assistance Program if:
- Your clinic or infusion center does not accept payment for medication costs directly from the VYEPTI CONNECT Copay Assistance Program
- You have paid for your VYEPTI medication costs while enrolled in the VYEPTI CONNECT Copay Assistance Program
If eligible for direct reimbursement, please mail or fax your explanation of benefits (EOB) and receipt to the VYEPTI CONNECT Copay Assistance Program at:
MAIL:
VYEPTI CONNECT Copay Assistance Program
2250 Perimeter Park
Suite 300
Morrisville, NC 27560
FAX:
866-218-3479
I Have Medicare, Medicaid or other Government Insurance Plan
The Vyepti Copay Assistance Program is not available to patients whose medical insurance is provided by state or federal programs, like Medicare and Medicaid. This restriction is true for all CGRP inhibitor medications.
The Federal Government does not allow people who are receiving insurance benefits through Medicare, Medicaid, etc. to use co-pay assistance, discount or savings cards offered by pharmaceutical companies. The intent is to steer patients to lower-cost generic drugs and not to support higher-cost brand-name drugs. Unfortunately, there are no generic/biosimilar medications in the class of CGRP inhibitors and won’t be for years to come.
I Am Uninsured
The Vyepti Copay Assistance Program is not available to patients who are uninsured.
Uninsured patients or those without insurance coverage for Vypeti can find more information about Lundbeck Migraine Patient Assistance Program by calling the Support Center at 877-288-9125 or on the Lundbeck website at lundbeck.com/us/our-commitment/patient-assistance. The support center will assess each patient on a case-by-case basis to determine whether he or she meets the program’s eligibility criteria.
Where do I turn if I am not eligible for a financial assistance program?
The Patient Advocate Foundation (a CHAMP participant organization) can be a helpful resource for patients and caregivers who are experiencing access challenges. PAF provides a suite of expert tips to help navigate insurance denials, appeals and common barriers at: patientadvocate.org/migrainematters.
PAF also offers one-on-one case management assistance through its dedicated Migraine Careline for people living with migraine who experience access challenges. The Migraine Careline provides assistance with: navigating eligibility and enrollment in disability benefits; overcoming insurance coverage; and financial burdens that impact patient access to care.
All services are completely free and provided through phone and/or email communication. Visit migraine.pafcareline.org or call 866-688-3625 to speak with a case manager today.
Vyepti Basics
-
Brand Name
- Vyepti
-
Biologic Name
- eptinezumab-jjmr
-
Pharmaceutical Company
- Lundbeck Seattle Bio Pharmaceuticals
-
Website
- Vyepti.com/
-
Helpline
- 1-833-4-VYEPTI (1-833-4893784)
-
Additional Help Available
- Vyepti Go – a personalized support program to help patients through the Vyepti treatment journey.
-
Full Prescribing Information
- https://lundbeck.com/upload/us/files/pdf/Products/Vyepti_PI_US_EN.pdf
-
Dosing & Administration
- 100 mg as an intravenous infusion over approximately 30 minutes every 3 months. Some patients may benefit from a dosage of 300 mg. Your doctor will determine which option is best for you.
-
Indication
- Preventive treatment of migraine in adults.
-
Home Delivery Available
- Yes, Vyepti can be administered through a Home Healthcare provider. Home Infusion/Home Health agencies can obtain VYEPTI from the authorized distribution network.
